PATRICK LINK: Open Payments
NPI 1992767164 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 99 payments from 22 companies in 2025. Trend: 2023 $545 · 2024 $2,437 · 2025 $2,311
Food & beverage: $2,311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $410 |
| AstraZeneca Pharmaceuticals LP | 8 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $179 |
| Novo Nordisk Inc | 13 | $178 |
| Axsome Therapeutics, Inc. | 6 | $157 |
| Astellas Pharma US Inc | 7 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| SANOFI-AVENTIS U.S. LLC | 3 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $78 |
| GlaxoSmithKline, LLC. | 4 | $78 |
Products named: CAPLYTA, UBRELVY, AIRSUPRA, Auvelity, Veozah, VOQUEZNA, QULIPTA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
